• Users Online: 237
  • Print this page
  • Email this page


 Coming soon

EDITORIAL
1.  Patterns of care for ovarian cancer
2.  Molecular Tumor Board: CASE 1 Interplay of EGFR, MET and PD-L1 in Non-Small Cell Lung Carcinoma
3.  Health Related Quality of Life: Is it a missing feature in the Indian Cancer Setting?
4.  The need to know
5.  Treating Elderly with æyoungeræ evidence based therapy: Time to tailor to suit the fragility.
6.  Liquid biopsy in Lung Cancer - hope or hype ?
7.  Management of bone and soft tissue sarcomas- from state of practice to state of art
8.  Beyond the tumor and tumor milieu- Factors affecting responses to Immunotherapy
LETTER TO EDITOR
1.  Depth of tumor infiltration as a prognosticator in pT1-2 cN0 oral squamous cell carcinoma thereby need for elective neck dissection – A meta-analysis: Do we have the final verdict?
2.  Letter to Editor
3.  Clinical perspective in the management and outcomes of intraventricular tumours.
4.  Head-and-neck dermatofibrosarcoma protuberans: Scooping out data even in dearth of evidence
5.  Sailing through Lung Cancer Charted by EGFR Signposts
6.  Author reply to: Depth of tumor infiltration as a prognosticator in pT1-2 cN0 oral squamous cell carcinoma thereby need for elective neck dissection – A meta-analysis: Do we have the final verdict?
7.  “OUTCOMES IN RHABDOMYOSARCOMA – INDIAN PERSPECTIVE”
8.  Multiple Myeloma: The paradox and the challenge
9.  Treating EGFR positive advanced cancer lung – Did the water get muddier?
10.  Methotrexate Leukoencephalopathy
11.  Mental Health Care as Part of Cancer Care: A Call for Action
12.  Authorsæ reponse to: Dermatofibrosarcoma protuberans of head and neck: Clinical outcome of nine cases treated with imatinib
13.  Reviewing ROS1 IHC vis a vis FISH in NSCLC
14.  Panda eye sign on diffusion weighted-magnetic resonance imaging for diagnosis of methotrexate induced subacute leukoencephalopathy
15.  Posting in Varanasi: A Blessing in Disguise
16.  First line treatment of EGFR mutant NSCLC: Spoilt for choice??
17.  Changing landscape of induction therapy in newly diagnosed multiple myeloma
18.  Letter to Editor
19.  Author response to - Treating EGFR positive advanced cancer lung
20.  Determination of ROS1 positivity by immunohistochemistry in a multicentric cohort of 426 non‑small‑cell lung cancer cases in India
21.  Reducing the dose - Balancing act between just right and too less?
22.  Author reply
23.  Author Reply
24.  The efficacy of low dose immunotherapy (LDI) in head and neck cancer
25.  Desperate Times desperate measures: - Low dose Nivolumab in non-small cell Lung cancer (NSCLC)
ORIGINAL ARTICLE
1.  Ovarian cancer practice survey from SAARC ( South Asian Association for Regional Cooperation) nations
2.  Life and limb after limb salvage surgery for osteosarcoma in a tertiary cancer centre
3.  Outcomes with liquid biopsy Epidermal Growth Factor Receptor mutation status in poor performance, biopsy ineligible advanced Non Small Cell Lung Cancer
4.  Quality of Life and Needs of the Indian Advance Cancer Patients Receiving Palliative Care
5.  Artificial Intelligence in Healthcare and developing nations: The beginning of a transformative journey
6.  Concomitant use of corticosteroids and immune checkpoint inhibitors in patients with solid neoplasms: A real world experience from a tertiary cancer center
7.  UNPLANNED EXCISION IN SOFT TISSUE SARCOMAS– IS IT THE UNKINDEST CUT OF ALL?
8.  Basics of Statistics-1
9.  Survey for Geriatric Assessment(GA) in practicing oncologists in India
10.  Clinico-pathological Characteristics, Prognostic Factors and Outcomes in Peripheral T-Cell Lymphoma: Experience from a Single Centre in India.
PATIENT/ CAREGIVER CORNER
1.  æWhy Second Opinions Matter - My father’s journey from palliative treatment to a curative oneæ
CASE REPORT
1.  Oncology and pregnancy:Image wisely.
2.  Images In Clinical Oncology Stories of two eyes:- What to look in patient eyes?
3.  MYSTERY OF JAW PAIN
REVIEW ARTICLE
1.  ROLE OF PALLIATIVE CHEMOTHERAPY AND TARGETED THERAPY IN ADVANCED ESOPHAGEAL AND GASTROESOPHAGEAL JUNCTION CANCER
2.  Ponatinib- A Drug review